These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6486271)

  • 1. Case report of barbiturate-induced enhancement of methadone metabolism and withdrawal syndrome.
    Liu SJ; Wang RI
    Am J Psychiatry; 1984 Oct; 141(10):1287-8. PubMed ID: 6486271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the withdrawal responses of heroin and methadone addicts during detoxification.
    Gossop M; Strang J
    Br J Psychiatry; 1991 May; 158():697-9. PubMed ID: 1860023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valproic acid, unlike other anticonvulsants, has no effect on methadone metabolism: two cases.
    Saxon AJ; Whittaker S; Hawker CS
    J Clin Psychiatry; 1989 Jun; 50(6):228-9. PubMed ID: 2498296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum methadone as an aid in managing methadone maintenance patients.
    Walton RG; Thornton TL; Wahl GF
    Int J Addict; 1978 Jul; 13(5):689-94. PubMed ID: 721328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Withdrawal from heroin and methadone.
    Travers R
    Br J Psychiatry; 1991 Oct; 159():582-3. PubMed ID: 1751876
    [No Abstract]   [Full Text] [Related]  

  • 6. Naltrexone-assisted rapid methadone discontinuation: a pilot study.
    Camarasa X; Khazaal Y; Besson J; Zullino DF
    Eur Addict Res; 2007; 13(1):20-4. PubMed ID: 17172775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case report on methadone withdrawal syndrome].
    Chuang P
    Hu Li Za Zhi; 2009 Dec; 56(6):95-100. PubMed ID: 19953462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid detoxification from opioid dependence under general anaesthesia versus standard methadone tapering: abstinence rates and withdrawal distress experiences.
    Krabbe PF; Koning JP; Heinen N; Laheij RJ; van Cauter RM; De Jong CA
    Addict Biol; 2003 Sep; 8(3):351-8. PubMed ID: 13129838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rifampin-induced methadone withdrawal.
    Kreek MJ; Garfield JW; Gutjahr CL; Giusti LM
    N Engl J Med; 1976 May; 294(20):1104-6. PubMed ID: 1256526
    [No Abstract]   [Full Text] [Related]  

  • 10. [Substance dependence and pregnancy. Experience in care].
    Bussolino S; Tibaldi C; Mansueto MG; Todros T; Geda O; Sanfelici C; Gagliardi L
    Minerva Ginecol; 1986 Nov; 38(11):895-902. PubMed ID: 3808423
    [No Abstract]   [Full Text] [Related]  

  • 11. Plasma methadone concentrations as an indicator of opioid withdrawal symptoms and heroin use in a methadone maintenance program.
    Torrens M; Castillo C; San L; del Moral E; González ML; de la Torre R
    Drug Alcohol Depend; 1998 Nov; 52(3):193-200. PubMed ID: 9839145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of heroin and methadone on plasma cortisol and testosterone.
    Mendelson JH; Meyer RE; Ellingboe J; Mirin SM; McDougle M
    J Pharmacol Exp Ther; 1975 Nov; 195(2):296-302. PubMed ID: 1185598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical comparison of propoxyphene napsylate and methadone in the treatment of opiate dependence.
    Wang RI; Kochar C; Hasegawa AT; Roh BL
    NIDA Res Monogr; 1982 Apr; 41():253-60. PubMed ID: 6126814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical mismanagement in public methadone programs.
    Blansfield HN
    Conn Med; 1994 Mar; 58(3):161-4. PubMed ID: 8039380
    [No Abstract]   [Full Text] [Related]  

  • 15. Plasma levels and symptom complaints in patients maintained on daily dosage of methadone hydrochloride.
    Horns WH; Rado M; Goldstein A
    Clin Pharmacol Ther; 1975 Jun; 17(6):636-49. PubMed ID: 1139855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of methadone versus methadone and guanfacine in the detoxification of heroin-addicted patients.
    San L; Fernandez T; Cami J; Gossop M
    J Subst Abuse Treat; 1994; 11(5):463-9. PubMed ID: 7869468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Slow tapering from methadone maintenance in a program encouraging indefinite maintenance.
    Calsyn DA; Malcy JA; Saxon AJ
    J Subst Abuse Treat; 2006 Mar; 30(2):159-63. PubMed ID: 16490679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CSF-endorphins in heroin addicts during methadone maintenance and during withdrawal.
    Holmstrand J; Gunne LM; Wahlström A; Terenius L
    Pharmacopsychiatria; 1981 Jul; 14(4):126-8. PubMed ID: 7280011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Subjective wellbeing in heroin withdrawal. With methadone the patient feels better].
    Giacomuzzi SM; Riemer Y; Kemmler G; Ertl M; Richter R; Rössler H; Hinterhuber H
    MMW Fortschr Med; 2001 Sep; 143(37):53. PubMed ID: 11599295
    [No Abstract]   [Full Text] [Related]  

  • 20. [Subjective wellbeing and somatic markers in methadone substitution. Evaluation of 61 heroin addicts].
    Giacomuzzi SM; Riemer Y; Kemmler G; Ertl M; Richter R; Rössler H; Hinterhuber H
    Fortschr Med Orig; 2001 Nov; 119(3-4):103-8. PubMed ID: 11789120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.